SMOKING AND MOVEMENT-DISORDERS IN PSYCHIATRIC-PATIENTS

被引:72
作者
MENZA, MA [1 ]
GROSSMAN, N [1 ]
VANHORN, M [1 ]
CODY, R [1 ]
FORMAN, N [1 ]
机构
[1] ROBERT WOOD JOHNSON UNIV MED SCH, DEPT PSYCHIAT, NEW BRUNSWICK, NJ USA
关键词
D O I
10.1016/0006-3223(91)90163-G
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies have suggested that tardive dyskinesia may occur more frequently in patients who smoke. Further evidence of an interaction between smoking and movement disorders includes the low lifetime exposure to cigarettes found in Parkinson's disease patients. In this study 126 patients with chronic psychiatric illness were blindly evaluated for tardive dyskinesia, neuroleptic-induced parkinsonism, and akathisia. Patients who smoked received significantly higher doses of neuroleptics but did not have significantly more frequent or more severe tardive dyskinesia or parkinsonism. Female smokers did have significantly more akathisia. These results are discussed with regard to interactions between smoking, central dopaminergic tone, and the psychopathology of extrapyramidal syndromes. The effect of smoking on neuroleptic blood levels as well as clinical symptomatology is also discussed.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 38 条
[21]  
Kessler I I, 1978, Adv Neurol, V19, P355
[22]   EPIDEMIOLOGIC STUDIES OF PARKINSONS DISEASE .1. SMOKING AND PARKINSONS DISEASE - SURVEY AND EXPLANATORY HYPOTHESIS [J].
KESSLER, II ;
DIAMOND, EL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1971, 94 (01) :16-&
[23]   HYPOTHESIS - A NICOTINE-DOPAMINE INTERACTION LINKING SMOKING WITH PARKINSONS-DISEASE AND TARDIVE-DYSKINESIA [J].
KIRCH, DG ;
ALHO, AM ;
WYATT, RJ .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1988, 8 (03) :285-291
[24]   EFFECT OF CHRONIC NICOTINE ADMINISTRATION ON MONOAMINE AND MONOAMINE METABOLITE CONCENTRATIONS IN RAT-BRAIN [J].
KIRCH, DG ;
GERHARDT, GA ;
SHELTON, RC ;
FREEDMAN, R ;
WYATT, RJ .
CLINICAL NEUROPHARMACOLOGY, 1987, 10 (04) :376-383
[25]   STIMULATION OF NIGROSTRIATAL DOPAMINE NEURONS BY NICOTINE [J].
LICHTENSTEIGER, W ;
HEFTI, F ;
FELIX, D ;
HUWYLER, T ;
MELAMED, E ;
SCHLUMPF, M .
NEUROPHARMACOLOGY, 1982, 21 (10) :963-968
[26]  
MARTTILA RJ, 1980, ACTA NEUROL SCAND, V62, P322
[27]  
MENZA MA, 1990, J NEUROPSYCHIATRY CL, P282
[28]  
NAQUIRA D, 1978, EUR J PHARMACOL, V47, P227, DOI 10.1016/0014-2999(78)90394-1
[29]   A RETROSPECTIVE STUDY OF SMOKING IN PARKINSONS DISEASE [J].
NEFZGER, MD ;
QUADFASEL, FA ;
KARL, VC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1968, 88 (02) :149-+
[30]  
OLDENDORF WH, 1974, P SOC EXP BIOL MED, V147, P813